Long-term progress of six cases of malignant peripheral nerve sheath tumors of the mediastinum that underwent surgical treatment: Case report series  by Nakajima, Yuki et al.
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INTRODUCTION:  Malignant  Peripheral  Nerve  Sheath  Tumor  is  a rare  type  of  soft  tissue  malignant  tumor
that occurs  in only  5%  of  cases.  It tends  to  occur  in the  arms  and  legs  and  trunk  of the  body,  with  mediastinal
occurrence  in  only  a few  cases.  Among  mediastinal  tumors,  only  18.8%  occur  primarily  in the  nerves,  and
of these,  only  10.3%  are  malignant,  with  very  few  reports  indicating  the long-term  progress  of  patients
with  MPNST  of the  mediastinum.
CASE  PRESENTATION:  We  studied  six  cases  of  mediastinal  primary  malignant  peripheral  nerve  sheath
tumors  in  which  surgery  was  carried  out  at this  Center  between  1977  and  2000.  Four  of  the cases  were
men  and  two  were  women.  The  period  of  observation  was  between  14  and  277  months  and  the  median
follow-up  time  was  119.5  months.  The  tumors  were  contained  in  a  membrane  and  completely  excisable
in  three  cases,  with  the  patient  demonstrating  long-term  survival  with  no recurrence  in each  case.  The
remaining  three  cases  were  not  completely  excisable  due  to invasion  into  the aorta.  In two  cases,  the
patients  were  treated  post-surgically  with  chemotherapy;  however,  in  all three  cases  the  patient  died  as
a result  of the  original  condition.
DISCUSSION  AND  CONCLUSIONS:  Nerve  sheath  tumors  localized  within  the  membrane  offer  good  long-
term  prognosis  even  if malignant.  Furthermore,  long-term  survival  is  possible  even if  the tumor  has
invaded  neighboring  organs,  provided  it can be  completely  excised.  In cases  where  complete  excision
is  difﬁcult,  a multidisciplinary  approach  including  radiotherapy  and  anti-cancer  drug  treatment  may
contribute  to  improved  prognosis  but this  is a subject  that requires  further  study.
©  2016  The  Authors.  Published  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Malignant Peripheral Nerve Sheath Tumor (MPNST) is a rare
ype of soft tissue malignant tumor that occurs in only 5% of cases
1]. It tends to occur in the arms and legs and trunk of the body, with
ediastinal occurrence in only a few cases [1]. Among mediastinal
umors, only 18.8% occur primarily in the nerves, and of these, only
0.3% are malignant, with very few reports indicating the long-
erm progress of patients with MPNST of the mediastinum [2]. In
his study, the authors considered the long-term surgical results of
ix cases of MPNST treated surgically at this hospital.
∗ Corresponding author at: 780 Komuro, Ina, Kita-adachi-gun, Saitama 362-0806,
apan.
E-mail address: yuki@cancer-c.pref.saitama.jp (Y. Nakajima).
ttp://dx.doi.org/10.1016/j.ijscr.2016.05.006
210-2612/© 2016 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing G
reativecommons.org/licenses/by-nc-nd/4.0/).2. Presentation of cases
We studied the long-term progress of six patients undergoing
surgery at this Center between 1977 and 2000 for mediastinal
primary malignant peripheral nerve sheath tumors. Four of the
patients were men  and two were women. Their ages ranged from
17 to 72 years (averaging 51 years). The primary location was the
anterior mediastinum in three cases, middle mediastinum in one
case and superior mediastinum in two  cases. The tumor diameter
was between 70 and 150 mm (average 101.8 mm). (Table 1) The
period of observation was  between 14 and 277 months and the
median follow-up time was  119.5 months. None of the cases had a
diagnosis prior to surgery; however, swift diagnosis during surgery
led to suspicion of a malignant nerve sheath tumor. In three of the
six cases (Cases 2, 4 and 5) the tumor was enclosed in a membrane,
with no invasion of the surrounding area, enabling complete exci-
sion thereof (Fig. 1). Cases 2 and 4 were treated with surgery alone,
while Case 5 went on to undergo radiotherapy. All three of these
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Table 1
Mediastinal MPNST:characteristics.
Case Age Sex Symptoms Location Size(mm) Preoperative diagnosis
1 17 M Back pain, Cough P 150 Neurogenic tumor
2  65 M – S 75 Mediastinal tumor
3  50 M Back pain P 70 Neurogenic tumor
4  45 F Chest oppression, Cough M 86 Lung tumor
5  55 F – S 110 Mediastinal tumor
6  72 M Back pain P 120 Schwannoma
P: posterior mediastinum, S: superior mediastinum, M,  middle mediastinum.
Table 2
Treatment and outcome.
Case Surgical approach Surgical treatment CT RT Recurrence Follow-up (months)
1 PL Extirpation (incomplete) + 40 Local, brain 69, death
2  MS Extirpation − − − 170, deatha
3 PL Exploratory thoracotomy + 70 14, death
4  PL Extirpation − − − 277, alive
5  MS Extirpation − 46 − 255, alive
6  PL Extirpation − − local 18, death
CT: Chemotherapy, RT: Radiotherapy, PL: posterolateral, MS:  median sternotomy.
a Died of other disease.
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6ig. 1. (A) Intraoperative image of case 4. The tumor originated from the vagus
erve. (B) Intraoperative image of case 4. The tumor could be smoothly detached
rom the aorta.ases went on to have long-term survival of ten years or more with
o recurrence. The remaining three cases (Cases 1, 3 and 6) involved
nvasion into the aorta and could not be completely excised. In Case
, the lung and aorta were also excised, but surgical margins werepositive. In Cases 1 and 3, the patients were post-surgically treated
with chemoradiotherapy, but in Case 6, no further treatment was
carried out because of the poor physical state of the patient. All
three of these patients died from the original condition (Table 2).
3. Discussion
The ﬁve-year survival rate for MPNST is between 34 and 43.7%.
Localized recurrence after excision is 46–65%, with the distal
metastasis rate considered between 40 and 68% [3–5]. Factors in
poor prognosis include: 1. Age at onset of 30 or lower; 2. Large
tumor diameter; 3. Occurrence inside the trunk; 4. Complicated
by nerve ﬁber tumor type 1; and 5. Incomplete excision, with the
three cases in this study that died having factors 2, 3 and 5 [3,4,6].
During treatment of MPNST, it is important to completely surgi-
cally excise the tumor. In the cases in this study, the three patients
whose tumors were enclosed in a membrane and could be com-
pletely excised all survived with no recurrence. Many tumors occur
on the surface of the limbs or trunk, allowing them to be discov-
ered early and completely excised; however, those occurring inside
the chest or abdomen take longer for the symptoms to express
and in many cases discovery is delayed, meaning that the tumor
grows and in many cases can no longer be completely excised upon
discovery, or may  be inoperable. Chemotherapy or radiotherapy
has conventionally been implemented on cases in which complete
excision cannot be performed, or inoperable cases; however, the
results are insufﬁciently effective. More recently, however, reports
note cases in which high dose Ifosfamide, vincristine, doxorubicin,
cyclophosphamide have been notably effective, as well as cases in
which post-surgery high dose radiation was effective, and those
in which boron neutron capture therapy has been effective [7–9].
In the future, further studies need to be conducted to establish
the effectiveness of these therapies. In Case 1 in this study, the
patient was post-surgically treated with 60 Gy radiotherapy and
cyclophosphamide, along with the anticancer drug cisplatin, which
yielded temporary results, achieving survival for 69 months.
4. ConclusionThis study considered the long-term surgical results in six cases
of mediastinally occurring MPNST treated at this hospital. MPNST
localized within the membrane, which can be completely excised,
offer good long-term prognosis. Furthermore, long-term survival is
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ossible even if the tumor has invaded neighboring organs, provid-
ng it can be completely excised. In cases where complete excision is
ifﬁcult, a multidisciplinary approach including radiotherapy and
nti-cancer drug treatment may  contribute to improved prognosis
ut this is a subject that requires further study.
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